EI
NPSP

EAM Investors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

EAM Investors’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-49,983
Closed -$1.65M – 413
2014
Q2 		$1.65M Buy
49,983
+11,548
+30% +$334K 0.31% 117
2014
Q1 		$1.15M Sell
38,435
-13,247
-26% -$457K 0.21% 272
2013
Q4 		$1.57M Buy
51,682
+4,341
+9% +$120K 0.28% 133
2013
Q3 		$1.51M Buy
+47,341
New +$1.09M 0.3% 123

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's NPSP Position: Q3 2014 in Review

EAM Investors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 49,983 shares — an estimated $1.65M sold.

EAM Investors first reported a position in NPSP in Q3 2013 and held it in 4 quarters. The position peaked at $1.65M in Q2 2014. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • EAM Investors reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • EAM Investors sold 49,983 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.65M.
  • EAM Investors first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 4 quarters.
  • EAM Investors's NPS PHARMACEUTICALS INC position peaked at $1.65M in Q2 2014.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on EAM Investors's 13F filing for Q3 2014, filed 13 Nov 2014.